艾力斯:季报点评:“内生+外延”双轮驱动业绩增长

化学制药 分析师:李琳琳 登记编码:S0730511010010 lill@ccnew.com 021-50586983 "内生+外延"双轮驱动业绩增长 ——艾力斯(688578)季报点评 | --- | --- | --- | --- | |------------------------------|------------------------------------------------------------------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...